Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
09 May 2019 | Story Ruan Bruwer | Photo Varsity Sports
Lefébre Rademan
Lefébre Rademan, new captain of the Free State Crinums netball team, could be one of the star players in the Premier League. She is a fifth-year Education student.

The Free State Crinums netball team, a de facto Kovsie team with all 15 squad members enrolled for courses at the University of the Free State (UFS), will draw inspiration from their success in last year’s Varsity netball tournament. The Kovsies won the student competition for a record third time. 

During the weekend of 10 May 2019, the Crinums will play their first match in the 2019 Premier League. They lost a couple of key players in captain Alicia Puren, Protea Khanyisa Chawane, (both playing for the national invitational team in the league), Khomotso Mamburu (moved to Cape Town), and Meagan Roux (injured). They do, however, still have the services of players such as Tanya von Berg (playing in her sixth Premier League, one of only a handful of players to do so), Lefébre Rademan, Sikholiwe Mdletshe, Ané Retief, Gertriana Retief, and Rieze Straeuli. Rademan is the new captain and was one of the standout players in last year’s Varsity netball, earning three Player of the Match awards, including the Player of the Final. 

The team will again be coached by Burta de Kock, who is also the head coach of the Kovsies. Under her leadership, the Crinums won the Premier League for the first three years (2014 to 2016). Last year, the Crinums ended fourth. De Kock will be assisted by Martha Mosoahle-Samm. She is a former Protea assistant coach who also captained South Africa and played for the UFS between 1997 and 1999.

There are four first-year students in the squad of 15 players: Oageng Khasake (wing attack), Ancia Pienaar (goalkeeper), Rolene Streutker (goal shooter), Boitumelo Mahloko (goal defence). Pienaar and Mahloko both represented South Africa at junior level in 2018.

■ Crinums squad: Ané Retief, Gertriana Retief, Jana Scholtz, Lefébre Rademan, Sikholiwe Mdletshe, Tanya von Berg, Rieze Straeuli, Claudia van den Berg, Zandré Smit, Oageng Khasake, Bianca de Wee, Ancia Pienaar, Rolene Streutker, Chanel Vrey, Boitumelo Mahloko.


News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept